Shockwave Medical falls amid speculation Boston Scientific talks have broken down
May 08, 2023 10:02 AM ETShockwave Medical, Inc. (SWAV), BSXBy: Joshua Fineman, SA News Editor5 Comments

Parradee Kietsirikul
- Shockwave Medical (NASDAQ:SWAV) fell 4.6% amid speculation that talks with Boston Scientific (NYSE:BSX) about a takeover have fallen apart. Boston Scientific rose 3.3%.
- Discussions about a takeover have broken down as a deal price couldn't be agreed upon, according to a Street Insider report on Monday, which cited an unidentified source. Boston Scientific (BSX) was said to have offered $275 a share for Shockwave (SWAV). The companies told the publication that they don't comment on rumors or speculation.
- The latest report comes after Bloomberg last month reported that Boston Scientific (BSX) was said to be considering a takeover of Shockwave (SWAV).
- Executives on Boston Scientific's (BSX) Q1 earnings call late last month repeatedly declined to comment on a recent report about a potential takeover of Shockwave (SWAV).
Recommended For You
Comments (5)
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

artiest
08 May 2023
275, while price was almost 300, normal that deal didn’t go through. Good news that deal didnt take place, within Bsx , future value of swav would shrimp away…

smadadet
08 May 2023
I'm glad SWAV didn't give in. The stock will reach $375 within the next year and still has a lot of upside as they are barely penetrating the potential market.
m

Off His Game
08 May 2023
When the talks started SWAV was likely around $200 - now that its had several pieces of good news (CPT code coming) the stock has rallied to at least $250 before this making $275 not good enough for SWAV management.
